Tag Archives: IOM

Burning Underground

Just over a year ago, advocate Leela Play noticed something odd on a federal contracting website. What she found was a notice of intent to award a sole source contract to the Institute of Medicine to create clinical diagnostic criteria … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , | 11 Comments

P2P: The Question They Will Not Ask

by Mary Dimmock and Jennie Spotila The most important question about ME/CFS – the question that is the cornerstone for every aspect of ME/CFS science – is the question that the P2P Workshop will not ask: How do ME and … Continue reading

Posted in Advocacy, Commentary, Research | Tagged , , , , , , , , , | 38 Comments

Guest Post: Longtime Patient, New Advocate

I am very pleased to share this guest post from Darlene Prestwich in which she shares her experiences as a new(ish) advocate. I’ve been doing this so long, sometimes I forget what it was like to jump in the deep … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , | 12 Comments

Guest Post: CFSAC Testimony of Andrew Bokelman

Andrew Bokelman was scheduled to deliver public comment to the CFS Advisory Committee on June 17th and was the first telephone commenter. His call was terminated by the operator prior to his 3 minutes being up. After protest on Andrew’s … Continue reading

Posted in Advocacy | Tagged , , , , , , , , | 5 Comments

Guest Post: CFSAC Comments of Charmian Proskauer

Charmian delivered these comments at today’s CFS Advisory Committee meeting. She has kindly given me permission to publish them here in their entirety. My name is Charmian Proskauer, and I currently serve as President of the Massachusetts CFIDS/ME & FM … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 1 Comment

A Different CFSAC

It’s that time again: meaning it is time for another CFS Advisory Committee meeting. Due to the make up day in March, the meetings have fallen very close together. Presumably this spring meeting puts the calendar back on track (but … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , | Comments Off

Will the Real P2P Please Stand Up?

What is the purpose of the ME/CFS P2P meeting at NIH? You would think that we would know by now, since Assistant Secretary Dr. Howard Koh first announced the effort in October 2012. But to say the rhetoric has evolved … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , | 22 Comments

IOM: Sum of the Whole Matter

The IOM panel on ME/CFS held its second (and likely final) public meeting on May 5, 2014. On display near the meeting room was this painting by Robert Van Vranken: Untitled (Everything at once, or one thing at a time?). … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 12 Comments

Protocol for Disaster?

The study protocol for the systematic review of ME/CFS was posted by the Agency for Healthcare and Research Quality yesterday. It’s a recipe for disaster on its own, and within the broader context of the NIH P2P Workshop it’s even … Continue reading

Posted in Advocacy, Commentary, Research | Tagged , , , , , , , , , , , , , , , , , | 44 Comments

Don’t Silence Yourself

On May 5th, the IOM panel creating new diagnostic criteria for ME/CFS will hold its second public meeting. The only way you can provide input is by submitting written comments, unless you are an invited speaker. I’m here to plead … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , | 62 Comments